PNV 1.27% $2.34 polynovo limited

Ann: 1H FY22 Results Presentation, page-370

  1. 5,487 Posts.
    lightbulb Created with Sketch. 8940
    well what I've tried to highlight is what I think the analysts are thinking and I feel is going to impact the short term share price. I can see Macqaurie already lowered their 12 month price target to $1.60 ... and I suspect the rest will follow.

    the fact that management are now targeting break-even in FY22 as a success, to borrow their phrase, will have the 'desired effect' of reducing company valuations. Just look at Macquarie this morning:

    • EPS revisions of -212%/-68%/-41% in FY22/23/24E (noting a low earnings
    base) reflect lower BTM forecasts, increased cost assumptions, updated FX.
    TP cut to A$1.60 (from A$2.85) in line with EPS changes, increased house
    risk-free-rates and a reduced Hernia valuation (A$0.20 from A$0.40).
    Price catalyst
    • 12-month price target: A$1.60 based on a DCF methodology.

    no need for 'I told you so' statements.. we all want to do well, and I honestly do wish everyone well.
    Last edited by stockrock: 28/02/22
 
watchlist Created with Sketch. Add PNV (ASX) to my watchlist
(20min delay)
Last
$2.34
Change
-0.030(1.27%)
Mkt cap ! $1.616B
Open High Low Value Volume
$2.41 $2.43 $2.32 $5.953M 2.536M

Buyers (Bids)

No. Vol. Price($)
3 29039 $2.33
 

Sellers (Offers)

Price($) Vol. No.
$2.35 16702 3
View Market Depth
Last trade - 16.10pm 30/08/2024 (20 minute delay) ?
PNV (ASX) Chart
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.